Related Experiment Video
Updated: Mar 3, 2026
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.3K
E-Science technologies in a workflow for personalized medicine using cancer screening as a case study.
Ola Spjuth1,2, Andreas Karlsson1, Mark Clements1
1Department of Medical Epidemiology and Biostatistics and Swedish e-Science Research Centre, Karolinska Institutet, Stockholm, Sweden.
Summary
This study presents an e-Science workflow for personalized medicine, enhancing cancer screening and intervention strategies through data-driven approaches. The framework supports biomarker discovery and decision-making for tailored patient care.
Area of Science:
- e-Science applications in healthcare
- Computational biology and bioinformatics
- Personalized medicine and genomics
Background:
- The increasing complexity of disease necessitates advanced computational approaches for effective prevention and control.
- Personalized interventions require robust frameworks for risk factor discovery, disease classification, and treatment evaluation.
- The e-Science for Cancer Prevention and Control (eCPC) initiative in Sweden aims to bridge this gap.
Purpose of the Study:
- To present a structured e-Science workflow for personalized medicine, from risk factor identification to intervention program evaluation.
- To illustrate the application of this workflow using case studies in personalized prostate and breast cancer screening.
- To highlight the role of e-Science tools in advancing evidence-based personalized healthcare.
Main Methods:
- Description of the generic 4-node iterative workflow developed by the eCPC initiative.
- Application of e-Science principles, utilizing mathematical, statistical, data, and computer science tools.
- Case study illustrations for prostate cancer (Stockholm-3 model) and breast cancer (biomarker development).
Main Results:
- The Stockholm-3 model (S3M) is proposed as an improved screening tool for prostate cancer, offering an alternative to PSA testing.
- Development of novel breast cancer biomarkers focusing on breast density and molecular profiles.
- Discussion of a coherent data integration platform for eCPC, moving beyond traditional data warehousing.
Conclusions:
- e-Science tools are fundamental for evidence-based personalized medicine.
- The presented workflow provides a structured pathway from data to the evaluation of personalized interventions.
- The eCPC workflow's concepts are transferable to other disease domains, emphasizing the need for multidisciplinary collaboration and tailored solutions.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:18Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K